Clinical Trials Directory

Trials / Terminated

TerminatedNCT00641784

Tocolytics Trial: Intravenous (IV) Magnesium Versus Oral Nifedpine in Fetal Fibronectin (FFN) Postive Population

A Randomized Trial of Oral Nifedipine Versus Intravenous Magnesium Sulfate in the Acute Management of Preterm Labor in Women With Singleton Gestations, Intact Fetal Membranes, and Positive Vaginal Fetal Fibronectin

Status
Terminated
Phase
Phase 3
Study type
Interventional
Enrollment
200 (estimated)
Sponsor
MemorialCare · Academic / Other
Sex
Female
Age
18 Years – 55 Years
Healthy volunteers
Not accepted

Summary

In women with singleton gestations, to contemporarily assess the efficacy of oral nifedipine versus intravenous magnesium sulfate in the acute management of preterm labor in terms of defined early and late neonatal measures

Conditions

Interventions

TypeNameDescription
DRUGMagnesiumIntravenous Magnesium 6 gram load, 3 grams/hr
DRUGNifedlipineOral Nifedpine 10 mgs q 20 min to effect (max 40mgs)...then 20 mgs q 4hrs

Timeline

Start date
2008-03-01
Primary completion
2012-03-01
Completion
2012-03-01
First posted
2008-03-24
Last updated
2009-09-18

Locations

1 site across 1 country: United States

Source: ClinicalTrials.gov record NCT00641784. Inclusion in this directory is not an endorsement.

Tocolytics Trial: Intravenous (IV) Magnesium Versus Oral Nifedpine in Fetal Fibronectin (FFN) Postive Population (NCT00641784) · Clinical Trials Directory